TY - JOUR
T1 - Inappropriate prescription of low molecular weight heparins for thromboprophylaxis among older hospitalized patients
AU - Garasto, Sabrina
AU - Fusco, Sergio
AU - Onder, Graziano
AU - Sganga, Federica
AU - Mammarella, Federica
AU - Volpato, Stefano
AU - Ruggiero, Carmelinda
AU - Abbatecola, Angela M.
AU - Lattanzio, Fabrizia
AU - Corsonello, Andrea
PY - 2017
Y1 - 2017
N2 - Aim: To investigate the prevalence and clinical correlates of overprescribing and underprescribing of low molecular weight heparins (LMWHs) for thromboprophylaxis among older medical inpatients. Methods: Eight hundred seventy six patients (mean age 81.5 ± 7.6 years, female gender 57.2 %) enrolled in a multicenter observational study of seven acute care wards of geriatric medicine in Italy. The risk of venous thromboembolism was ascertained by calculating the Padua score for each patient. Patients receiving appropriate prescription of LMHW during stay were compared to those receiving LMHW with a Padua score <4 (overprescribing group). Similarly, patients with a high thromboembolic risk (Padua score â¥4) but not receiving LMHW (underprescribing group) were compared to patients appropriately not receiving LMHW during stay. Independent correlates of overprescribing and underprescribing were investigated by logistic regression analysis. Results: Overall, 42.8 % of patients had a Padua score â¥4. LMWHs were overprescribed in 7.3 % and underprescribed in 25.2 % of patients. The number of lost basic activities of daily living (BADL) (OR = 0.25; 95 % CI 0.15â0.41) and the number of diagnoses (OR = 0.76; 95 % CI 0.61â0.95) were inversely associated with LMWH overprescription. Conversely, older age (75â84 years: OR = 2.39; 95 % CI 1.10â5.19â85 years or more: OR = 3.25, 95 % CI 1.40â7.61), anemia (OR = 1.80, 95 % CI 1.05â3.16), pressure sores (OR = 4.15, 95 % CI 1.20â14.3), number of lost BADL at the admission (OR = 3.92, 95 % CI 2.86â5.37) and number of diagnoses (OR = 1.29, 95 % CI 1.15â1.44) qualified as significant correlates of LMWH underprescription. Discussion: Underprescription and, to a lesser extent, overprescription still represent an issue among older medical inpatients. Conclusion: Implementing risk-stratifying scores into clinical practice may improve appropriateness of LMWHs prescribing during hospitalization.
AB - Aim: To investigate the prevalence and clinical correlates of overprescribing and underprescribing of low molecular weight heparins (LMWHs) for thromboprophylaxis among older medical inpatients. Methods: Eight hundred seventy six patients (mean age 81.5 ± 7.6 years, female gender 57.2 %) enrolled in a multicenter observational study of seven acute care wards of geriatric medicine in Italy. The risk of venous thromboembolism was ascertained by calculating the Padua score for each patient. Patients receiving appropriate prescription of LMHW during stay were compared to those receiving LMHW with a Padua score <4 (overprescribing group). Similarly, patients with a high thromboembolic risk (Padua score â¥4) but not receiving LMHW (underprescribing group) were compared to patients appropriately not receiving LMHW during stay. Independent correlates of overprescribing and underprescribing were investigated by logistic regression analysis. Results: Overall, 42.8 % of patients had a Padua score â¥4. LMWHs were overprescribed in 7.3 % and underprescribed in 25.2 % of patients. The number of lost basic activities of daily living (BADL) (OR = 0.25; 95 % CI 0.15â0.41) and the number of diagnoses (OR = 0.76; 95 % CI 0.61â0.95) were inversely associated with LMWH overprescription. Conversely, older age (75â84 years: OR = 2.39; 95 % CI 1.10â5.19â85 years or more: OR = 3.25, 95 % CI 1.40â7.61), anemia (OR = 1.80, 95 % CI 1.05â3.16), pressure sores (OR = 4.15, 95 % CI 1.20â14.3), number of lost BADL at the admission (OR = 3.92, 95 % CI 2.86â5.37) and number of diagnoses (OR = 1.29, 95 % CI 1.15â1.44) qualified as significant correlates of LMWH underprescription. Discussion: Underprescription and, to a lesser extent, overprescription still represent an issue among older medical inpatients. Conclusion: Implementing risk-stratifying scores into clinical practice may improve appropriateness of LMWHs prescribing during hospitalization.
KW - Activities of Daily Living
KW - Aged
KW - Aged, 80 and over
KW - Aging
KW - Anticoagulants
KW - Elderly
KW - Female
KW - Geriatrics and Gerontology
KW - Heparin, Low-Molecular-Weight
KW - Hospital
KW - Hospitalization
KW - Humans
KW - Inappropriate Prescribing
KW - Inappropriate prescription
KW - Low molecular weight heparins
KW - Male
KW - Practice Patterns, Physicians'
KW - Risk Assessment
KW - Risk Factors
KW - Venous Thromboembolism
KW - Activities of Daily Living
KW - Aged
KW - Aged, 80 and over
KW - Aging
KW - Anticoagulants
KW - Elderly
KW - Female
KW - Geriatrics and Gerontology
KW - Heparin, Low-Molecular-Weight
KW - Hospital
KW - Hospitalization
KW - Humans
KW - Inappropriate Prescribing
KW - Inappropriate prescription
KW - Low molecular weight heparins
KW - Male
KW - Practice Patterns, Physicians'
KW - Risk Assessment
KW - Risk Factors
KW - Venous Thromboembolism
UR - http://hdl.handle.net/10807/116606
UR - http://link.springer.com/journal/volumesandissues/40520
U2 - 10.1007/s40520-016-0571-0
DO - 10.1007/s40520-016-0571-0
M3 - Article
SN - 1594-0667
VL - 29
SP - 483
EP - 490
JO - Aging clinical and experimental research
JF - Aging clinical and experimental research
ER -